Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 717, pseudogene (RNU6-717P) is a genomic sequence annotated as a pseudogene related to U6 small nuclear RNA (snRNA)[7][8]. U6 snRNA is a crucial non-coding RNA component of the spliceosome, participating in precursor mRNA splicing, but RNU6-717P itself is a pseudogene—meaning it is thought not to produce a functional RNA product or protein[7][3]. Pseudogenes like RNU6-717P are typically unexpressed "genomic fossils" arising from duplications or retrotranspositions and are not considered functional therapeutic targets[7][6]. The canonical U6 snRNA is highly conserved and central to splicing in eukaryotes, but RNU6-717P is not known to carry any direct functional, biomarker, or therapeutic relevance in human disease or drug targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 717, pseudogene (RNU6-717P).